Article & Resources
A new, independent report from the York Health Economics Consortium (YHEC) on prostate cancer biopsies, has validated the improved health outcomes and economic benefits of the PrecisionPointTM transperineal prostate biopsy methodology under local anaesthetic (LA TP).
BXTA welcomes European Commercial Leader & Clinical Applications Specialist team members amidst continued international growth.
Nurse-led service transformation: a pathway to professional advancement – and better patient care
A new research paper recently published gives further weight to the eradication of the transrectal (TR) prostate biopsy from the prostate cancer pathway.
New study adds evidence to the important role of MRI & systematic biopsy in prostate cancer diagnosis
Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control
THE SOUTH WEST CANCER ALLIANCE MOVES TOWARDS ERADICATION OF ‘TRUS’ PROSTATE CANCER BIOPSY
BXTACCELYON BECOMES GLOBAL DISTRIBUTION PARTNER FOR NEW ONLINE PROSTATE MRI SELF-LEARNING TOOL, MRI PRO, TO ENHANCE PROSTATE CANCER DIAGNOSIS
State of the Art Stokes Centre for Urology to host Two-day Uro-Oncology Masterclass covering latest Innovations in Prostate Cancer Pathway
Prostate cancer in Scotland: an evolutionary journey By Karen Walker, Clinical Nurse Specialist,Edinburgh Cancer Centre
BXTAccelyon attend the 9th Annual Urology in General Practice (UroGP) Symposium 2018
LDR Brachytherapy: A minimally invasive curative treatment with excellent oncological and functional outcomes
Better Quality of life scores after brachytherapy in comparison to radical prostatectomy
ASCENDE RT study: intermediate and high risk prostate cancer patients have double the survival chance with brachytherapy seeds
Implants boost odds of halting prostate cancer: Men treated with radioactive ‘seeds’ twice as likely to find disease has stabilised after five years
Sorry, there are currently no posts with that category.